We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0J8P market cap is 16.71B. The company's latest EPS is USD 10.1749 and P/E is 40.99.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.41B | 2.71B | 3.22B | 3.37B | 3.66B |
Operating Income | 552.85M | 694.52M | 932.03M | 898.77M | 1.1B |
Net Income | 427.72M | 581.78M | 744.85M | 679.09M | 845.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.83B | 2.29B | 2.44B | 2.75B | 3.26B |
Total Liabilities | 1.65B | 1.66B | 1.75B | 2.14B | 1.78B |
Total Equity | 177.83M | 632.8M | 689.99M | 608.74M | 1.48B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 459.16M | 648.06M | 755.55M | 542.98M | 906.51M |
Investing | -205.53M | -109.38M | -292.97M | -195.35M | -125.25M |
Financing | -286.41M | -248.42M | -697.41M | -370.94M | -442M |
Market Cap | 16.71B |
Price to Earnings Ratio | 40.99 |
Price to Sales Ratio | 9.46 |
Price to Cash Ratio | 76.31 |
Price to Book Ratio | 23.33 |
Dividend Yield | - |
Shares Outstanding | 83.05M |
Average Volume (1 week) | 750 |
Average Volume (1 Month) | 1.02k |
52 Week Change | 0.00% |
52 Week High | 201.19 |
52 Week Low | 201.19 |
Spread (Intraday) | 0 (0%) |
Company Name | Idexx Laboratories Inc |
Address |
corporation trust center 1209 wilmington, delaware 19801 |
Website | https://www.idexx.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions